MEDIANTECHNOLOGIES news, videos and press releases - Page 4
For more news please use our advanced search feature.
MEDIANTECHNOLOGIES - More news...
MEDIANTECHNOLOGIES - More news...
- Median Technologies Is Releasing Full Year 2020 Financial Results (audited) as Well as Q1 2021 Business Activity Indicators, Showing a Very Strong Growth
- Median Technologies: Highly Successful Capital Increase via a Private Placement of 28.1 Million Euros
- Median Technologies Launches a Capital Increase via a Private Placement
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of February 28th, 2021
- Median Technologies to Host a Live Webcast and Provide a Company Update on March 9th, 2021
- Median Strengthens its iBiopsy® Leadership Team With the Appointment of Thomas Bonnefont as Chief Operating and Commercial Officer and the Appointment of Mike Doherty as Sr. Strategy Advisor, Product Development
- iBiopsy®: Median Technologies Continues Its Strong Positioning in Early-Stage Diagnosis with a New iBiopsy® Clinical Development Plan on Lung Cancer Screening (LCS)
- iBiopsy®: Median Technologies Inks a Major Research Collaboration Agreement With the University of California San Diego (UC San Diego)
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31st, 2021
- Median Technologies: Half Year Liquidity Contract Statement
- Median Technologies Records a 51 % Increase of Its 2020 Annual Revenue (Unaudited Figures)
- Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of December 31st, 2020
- Median Technologies: Financial Communications Schedule for the First Half of 2021
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2020
- iBiopsy®: Promising Results on a Preliminary Study to Identify the Severity of the Disease in Patients With Non-Alcoholic Steatohepatitis (NASH)
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2020
- Median Technologies Records Its Eighth Consecutive Quarter of Revenue Growth
- Median Technologies Announces its H1 2020 Results
- Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of September 30th, 2020
- Median Technologies: Promising Results on the Use of the IBiopsy® Platform in the Context of Measuring the Anti-tumor Immune Response
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31st, 2020
- Median Technologies: Financial Communications Schedule for the Second Half Of 2020
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31st, 2020
- Half Year Median Technologies Liquidity Contract Statement Contracted with Louis Capital Markets UK LLP
- Median Technologies: Strong Business Activity for the First Half of 2020 (Unaudited Figures)
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30th, 2020
- Median Technologies Is Awarded the Euronext European Rising Tech Label
- Median Technologies to Host a Live Webcast and Provide a Company Update on July 9th, 2020
- Median Technologies Appoints Oern Stuge MD, MBA, to Its Board of Directors
- Median Technologies: iBiopsy®: Promising Results on a Preliminary Study to Evaluate the Risk of Tumor Recurrence in Patients With Primary Liver Cancer
